Poster Presentations

1. Constanze A. Weber, Leonard Moise, Janet E. Buhlmann, William D. Martin, Hendrik Veelken and Anne S. De Groot, De-Tolerization of Anti-DEC205 for HIV Subunit Vaccine Delivery, abstract, Vaccine Technology III, Nuevo Vallarta, 06/10.

2. Anne S. De Groot, Robert Malone, Toby Cohen, Liz McLaine, Matt Ardito, Bill Martin, Universal Flu Vaccines: Now more than Ever, abstract, Vaccine Technology III, Nuevo Vallarta, 06/10.

3. Leonard Moise, Jill Schriewer, William Martin, Jinhee Lee, Mark Buller, Sharon Frey and Anne S. De Groot, T-cell Epitope Vaccine Provides Complete Protection Against Lethal Vaccinia Infection In HLA Transgenic Mouse Model, abstract, Vaccine Technology III, Nuevo Vallarta, 06/10.

4. Tobias Cohen, Matthew Ardito, William Martin, Anne S. De Groot, Personalizing Immune Responses to Vaccines, Autoantigens, and Protein Therapeutics: The iTEM (individualized T Cell Epitope Measure) Tool, Vaccine Technology III, Nuevo Vallarta, 06/10.

5. Anne S. De Groot, Mark Buller, Sharon Frey, Steven Gregory, Steven Moss, Hardy Kornfeld, Jinhee Lee, Leonard Moise, William Martin. T cell-driven Vaccines: Now more than Ever. Oral Presentation Accepted to Vaccine Technology III, Nuevo Vallarta, 06/10.

6. Ardito, M., Cohen T., Martin B. De Groot AS. EpiMatrix: Tool for Accelerated Epitope Selection and Vaccine Design. Poster Presentation Accepted to Vaccine Technology III, Nuevo Vallarta, 06/10.

7. Leonard Moise, Janet E. Buhlmann, Constanze A. Weber, Angela Reslow, Barbara Martin, William D. Martin, and Anne S. De Groot. De-tolerization of anti-DEC-205 for HIV vaccine delivery. Submitted, AIDS Vaccine Conference, September 2010.

8. Anne S. De Groot, Mark Buller, Sharon Frey, Steven Gregory, Steven Moss5, Hardy Kornfeld6, Jinhee Lee, Leonard Moise, William Martin. Successful pre-clinical development of four T-cell epitope-driven vaccines; proof of principle in HLA transgenic mice. Vaccines, All Things Considered. Washington DC, November 2010.

9. De Groot AS, Cohen T, Moise L, Ardito M and Martin W. A method for individualizing the prediction of immunogenicity for vaccines and protein therapeutics: iTEM (individualized T Cell Epitope Measure). NFID Thirteenth Annual Meeting on Vaccine Research 2010 North Bethesda, MD.

10. De Groot AS and Moise L. Effective design of T-cell driven vaccines applied to the GAIA HIV vaccine: Advances in vaccine design based on current preclinical success. NFID Thirteenth Annual Meeting on Vaccine Research 2010 North Bethesda, MD.